Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02505841
Other study ID # 9488
Secondary ID 2014-A01431-46
Status Active, not recruiting
Phase N/A
First received June 22, 2015
Last updated July 20, 2015
Start date May 2015
Est. completion date June 2017

Study information

Verified date May 2015
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The transversus abdominis plane (TAP) block is a regional anesthetic technique for post operative pain control after abdominal surgical procedures. Its effectiveness in children undergoing laparoscopic appendectomy has not been demonstrated. The investigators evaluate its analgesic efficacy over the first 24 post operative hours.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 240
Est. completion date June 2017
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 1 Year to 12 Years
Eligibility Inclusion Criteria:

- Patient hospitalized in surgery and infantile anesthesia unit or admitted in emergencies for an laparoscopic appendectomy surgery.

- Patient whose general state corresponds to the classification of the American Society of Anesthesiologists (ASA) I to II

- Patient member in a national insurance scheme

Exclusion Criteria:

- Patient with drilled appendicitis or peritonitis

- Patient with a contraindication to local anesthesics

- Patient with a contraindication to TAP block

- Patient with allergies or known hypersensitivity to curare

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
TAP block with Ropivacaine
Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg
Drug:
Curare
Atracurium injection at 0.5 mg/kg at least 3 minutes before the surgical incision

Locations

Country Name City State
France CHRU Montpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Painkiller of help consumption Quantity of analgesic of help (Nalbuphine, Nubain®, Dupont Pharma, Paris, France) taken after the surgery. up to 24 hours after surgery No
Secondary Pain intensity after surgery The post-operative pain will be estimated from the arrival in recovery room with the Face Legs Activity Cry Consolability (FLACC) scale. up to 24 hours No
Secondary First demand of analgesic of help First demand of analgesic of help (Nubain ®) after the surgery up to 12 hours No
See also
  Status Clinical Trial Phase
Completed NCT03004222 - A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine N/A
Recruiting NCT06220513 - Erector Spinae Plane Block Versus TAP Block for Postoperative Analgesia of Laparoscopic Appendectomy N/A
Recruiting NCT02665000 - Evaluating the Effects of a Structured Training Program on the Learning Curve of Residents in Laparoscopic Surgery N/A
Recruiting NCT05761080 - Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics Phase 4